Key result
Management of bleeding in patients on antithrombotic agents requires risk stratification, individualized decision making, and specific bridging or haemotherapy strategies for high-risk situations.
Population
Patients using antithrombotic agents (antiplatelet agents and anticoagulants)
Design
Review
Authors
Loading...
May inform periprocedural decisions in antithrombotic patients; leaves open prospective trials to validate specific strategies.
This review outlines strategies for managing bleeding risks in patients on antithrombotic therapy, including bridging protocols for surgery and treatments for severe hemorrhage.
Rüdiger E. Scharf (2009) conducted a review in Thrombotic disorders requiring antithrombotic agents. Antithrombotic agents and bleeding management strategies was evaluated. Management of bleeding in patients on antithrombotic agents requires risk stratification, individualized decision making, and specific bridging or haemotherapy strategies for high-risk situations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: